Summary Male C57BL/65 mice received a basal diet supplemented with 4% soya-bean oil, linseed oil or fish oil, in which the major polyunsaturated fatty acids were linoleic acid, alpha-linolenic acid and long chain omega-3 fatty acids, respectively. Groups of animals were injected into the right flank with EL4-lymphoma cells, others with thymoma cells. Tumour implantation caused a gradual decrease in food consumption with both types of tumour, while body weight increased, especially in the EL4-bearing animals receiving the soya-bean diet. The weight gain was due to body water accumulation and was accompanied by decreases in body fat and minor changes in carcass protein and ash contents. The dietary treatments did not produce significant differences in tumour incidence and mortality, but tumour size was decreased by diets supplying omega-3 fatty acids: in the EM mice tumour weight was markedly depressed by linseed oil, compared to soya-bean oil, whereas thymoma tumour weight was lowest in mice receiving fish oil and highest in the soya-bean oil group. Both types of tumour caused pronounced hypoglycaemia and hyperinsulinaemia in the hosts, and the effect was modulated by the diets in the EL4 but not in the thymoma animals: the plasma glucose level was especially low in the linseed oil group and relatively highest in the soya-bean oil treatment. The degree of hyperinsulinaemia depended on the diet only in the thymoma-bearing mice, with linseed and fish oils producing higher insulin levels than soya-bean oil. A slight hyperinsulinaemia was also observed in linseed and fish oil-fed control mice. Serum triglycerides were elevated in tumour-bearing animals, without consistent differences between dietary treatments. Although no clear pattern emerged concerning total cholesterol and LDL levels, HDL values were strongly affected by the type of oil: in the control animals linseed oil caused an increase in HDL-cholesterol compared to the other two oils. The thymoma-bearing mice responded to the linseed and fish oil diets with greatly elevated HDL-cholesterol levels. The results point to important differences in the responses of the two implanted tumours and hosts not only to the omega-6 and omega-3 fatty acids, but also to the type of dietary omega-3 fatty acids, namely alpha-linolenic acid and long chain fish oil polyunsaturated fatty acids.
Omega-6 polyunsaturated fatty acids (PUFA) have been reported to increase the incidence, growth and metastasis of experimental tumours (Carroll & Hopkins, 1979; Carroll, 1980; Hubbard & Erickson, 1987; Roebuck et al., 1981) . On the other hand, recent studies using fish oils as a source of omega-3 PUFA suggest that these fatty acids either have no enhancing effect or cause inhibitory effects on some transplantable or carcinogen-induced tumours (Braden & Carroll, 1986; Carroll & Braden, 1984; Jurkowski & Cave, 1984 Karmali et al., 1984; Karmali, 1987; O'Connor et al., 1985; Reddy & Maruyama, 1986; Reddy & Sugie, 1988) .
The mechanisms of action of these PUFA on host and tumour are not fully established. Some reports suggest that linoleic acid, the parent fatty acid of the omega-6 family, potentiates tumorigenesis by providing structural and functional essential fatty acids to dividing cells and by serving as a precursor to oxygenated metabolites of arachidonic acid, among which PGE2 in turn may be involved in tumour development (Jurkowski & Cave, 1985; Hillyard & Abraham, 1979; Abraham & Hillyard, 1983; Carter et al., 1983) . On the other hand, the omega-3 parent compound, alpha-linolenic acid, inhibits linoleic acid conversion to arachidonic acid, and its long-chain derivative, eicosapentaenoic acid, interferes with the conversion of arachidonic acid to prostaglandins (Culp et al., 1979; Goodnight et al., 1982) .
High-PUFA diets, mainly those containing omega-3 PUFA, depress serum cholesterol (Phillipson et al., 1985) , evoke hyperinsulinaemia (Lardinois, 1987; Lardinois et al., 1987) and alleviate the alloxan-induced diabetic status in mice (Yam, 1989) . Hyperinsulinaemia is sometimes accompanied by hyperglycaemia or by postprandial glucose intolerance Hartog et al., 1987) .
Whereas conflicting observations have been reported regarding blood cholesterol and its possible role in cancer (De Waard, 1975; Fernleib, 1983; McMichael et al., 1984) , insulin has been shown to influence the development of various tumours by enhancing the growth of insulin-dependent tumours (Pavelic & Slijepcevic, 1978) and by inhibiting the insulin-sensitive ones (Cohen & Hilf, 1974 , 1975 Feldman & Hilf, 1985; Salter et al., 1958) . Therefore it may be suggested that the effect of dietary PUFA on tumours may also depend to some extent on the tumour-insulin relationship.
The influence of tumours on the host's food intake and body weight varies. Significant weight loss has been reported in patients with the appearance of the first symptoms of neoplasia (Robbins, 1974; Nathanson & Hall, 1974) . MAC 16 colon adenocarcinoma-bearing mice showed a progressive decrease in carcass weight as the tumour size increased (Bibby et al., 1987; Beck & Tisdale, 1987) , whereas an opposite trend was observed in thymoma-bearing mice (Pavelic & Slijepcevic, 1978) . While no drop in caloric intake was observed in the MAC 16 colon adenocarcinoma-bearing mice, anorexia was consistently seen in methylcholanthreneinduced sarcoma in Fisher rats (Moley et al., 1988) and in some human cancers (Nathanson & Hall, 1974) . It seems that the weight loss of the host is associated with a decrease in both fat and lean tissue (Beck & Tisdale, 1987; Moley et al., 1988) .
The purpose of the present study was to determine how diets differing in the contents of various omega-6 and omega-3 PUFA affect two transplantable tumours differing in their dependence on insulin: EL4-lymphoma, assumed to be an insulin-producing/secreting tumour (Yam et al., 1990) , and thymoma, an insulin-dependent tumour (Pavelic & Slijepcevic, 1978 A.G., Baden, FRG) . The fatty acid composition of the experimental oils and of the lipids extracted from the basal diet was determined by gas-liquid chromatography and the fattyacid contents of the experimental diets are presented in Table  II . The oils were mixed with the basal diet daily before filling the food cups and the food remaining from the previous day was discarded. 
Results
Tumour incidence and mortality Tumours were detected in EL4-bearing mice 7 days after tumour transplantation; the following day the incidence rose to about 80%. In the thymoma groups tumours appeared later, 15 days after transplantation, the incidence reaching 85% on day 19 after transplantation. Tumour incidence was not affected by the source of dietary oil.
Mortality closely followed the increase in tumour incidence. In the EL4 mice the first deaths occurred on day 13 after transplantation, and on day 16 most of the mice had died. In the thymoma group, mortality started on day 19 after transplantation and reached about 80% on day 25. Mortality was not affected by the source of dietary oil.
Food intake and body weight (Figure 1 ) Food intake decreased gradually in implanted mice, more rapidly in the thymoma than in the EL4-bearing mice. The source of dietary oil had a slight but consistent effect on food intake in the tumour-bearing mice, with the lowest values obtained with FO, the highest with SBO.
In the EL4 mice, tumour transplantation was followed by a marked increase in body weight (Figure 1 ) which was more pronounced in the mice fed SBO than in those fed LSO or FO. Thymoma implanted mice tended to lose weight, except the SBO group in which a moderate increase was seen.
Carcass content of water, protein, fat and ash (Table III) The increase in body weight of the EL4-bearing mice was due mainly to water accumulation, which was greater in the SBO group than in the other dietary treatments. Such an effect was not observed in the thymoma-bearing mice.
Protein and ash contents were less in the tumour-bearing mice than in the controls when the animals received LSO or FO, but such a tumour effect was not seen in the SBO-fed and oil (0) effects are highly significant (P <0.01), while the T x 0 interaction is significant (P <0.05); for weight gain, the T effect and the T x 0 interaction are significant (P <0.05). mice. The type of oil had no significant effect on body fat in the EL4 mice.
Tumour weight and composition (Table IV) Tumour weight was generally proportional to the increase in host body weight but there were differences due to the diets. In the EL4 mice receiving LSO tumour weight was smaller than in the SBO group (P <0.05) and in the FO supplemented animals (non-significant). In the thymoma mice, the tumour weight was lowest in the FO group and highest in the SBO treatment (P <0.05). The tumours contained less fat than the muscle excised from control mice, and fat concentration was lower in thymoma than in EL4. While in the EL4 mice, tumour fat concentration was not affected by the source of oil, in the thymoma mice, LSO depressed the tumour fat concentration more than SBO or FO.
Blood components (Table V) Glucose and insulin Glucose levels were much lower and insulin levels much higher in the tumour-bearing mice than in the controls. An interaction was obtained between the type of oil and the tumour. While the source of oil had no significant effect on glycaemia in the control mice, in the tumour-bearing animals dietary supplementation with LSO or FO was accompanied by a reduction of glucose, the effect being especially dramatic for EL4 mice receiving LSO. Thymoma mice responded to LSO and FO supplementation by an over two-fold increase in serum insulin compared to SO. A similar dietary effect was observed in the control mice but not in the EL4 bearing animals.
Serum triglycerides and cholesterol The main overall effect of tumour implantation was a highly significant increase in both triglycerides and cholesterol. FO caused a drop in total cholesterol in the controls and EL4 animals. The dietary oils had no significant effects. No clear pattern emerged concerning the relation between serum total cholesterol and the dietary treatments, although the overall effect of the diets was significant, with FO tending to produce the lowest values in control and EL4 mice.
LDL and HDL Tumour implantation resulted in increased HDL levels, especially in thymoma mice receiving LSO and FO. HDL values of control mice were elevated significantly by the LSO treatment. There were no significant differences between LDL values due to tumour implantation or oil treatments.
Discussion
Our results confirm the inhibitory action on tumour growth of fish oil, as first reported by Karmali et al. (1984) and Jurkowski and Cave (1984) for transplants of mammary tumours in rats and confirmed since then by others for a variety of experimental tumours (for a review see Karmali, 1987) . However, in our study, while the long-chain omega-3 fatty acids from FO caused a significant reduction in the weight of thymoma lymphoma, alpha-linolenic acid provided by LSO was most effective as an inhibitor of EL4 growth.
The anti-tumour activity of alpha-linolenic acid, in contrast to the more widely studied effects of long-chain fatty acids from fish oils, has been observed by others. For instance, Fritsche and Johnston (1988) recently reported an inhibitory effect of LSO on both growth and metastasis of a tumour cell line with strong metastatic properties transplanted into mice, compared to corn oil and FO. Antitumour effects of dietary alpha-linolenic acid were also reported for different animal models by Hori et al. (1987) and Cameron et al. (1989) . Our results, and those of Hori et al. (1987) lead to the conclusion that the antitumour potential of alpha-linolenic acid in different experimental models may differ from that of the long-chain omega-3 fatty acids from FO.
A factor causing considerable variability in the results is the amount of test oil added to the basal diet. For instance, menhaden oil at 20% in the diet reduced the growth and incidence of DMBA-induced mammary tumours, compared to 20% corn oil, but at 3% these oils yielded comparable results (Braden & Carroll, 1986) . Hopkins et al. (1981) found that 3% menhaden oil actually stimulated tumour growth in that same model. In the present study a relatively small amount of 4% test oil was added to a basal diet already containing 1% linoleic acid. It is therefore possible that the supply of a larger amount of omega-3 fatty acids, or an increased ratio of omega-3 to omega-6 fatty acids, would have caused more dramatic effects, especially in regard to tumour incidence and survival rate which were not significantly different in the dietary treatments for either of the two tumour models. Although no clearcut relation between blood cholesterol and triglycerides and tumourigenesis was found, tumourbearing mice were hypertriglyceridaemic (Table V) , which may be the result of intense mobilisation and depletion of carcass fat (Table III) .
The pronounced hyperinsulinaemia seen in tumourimplanted mice and especially in thymoma animals fed LSO or FO is of interest. It may have been caused by a combination of several factors: (a) increased insulin levels caused by the omega-3 fatty acids (Lardinois, 1987; Lardinois et al., 1987) , as also seen from the results obtained in the present study; (b) insulin secretion by such insulin-producing tumours as EL4 (Yam et al., 1990) ; and (c) enhanced secretion of insulin by the P-cells of the host's pancreas, induced by thymoma, presumably via some messenger (Pavelic & Slijepcevic, 1978) , a view that is also supported by results obtained with alloxan-diabetic mice (Yam et al., 1990) . High blood insulin levels are generally accompanied by development of insulin resistance in normal cells because of downregulation of insulin receptors, but this process is absent in tumour cells (Mountjoy et al., 1983 (Mountjoy et al., , 1987 . Hyperinsulinaemia would therefore be expected to inhibit insulin-sensitive tumours and confer advantages on insulin-dependent tumours, such as thymoma, but in fact, tumour weight was lowest in those dietary groups in which insulin levels were highest. We believe that under conditions of hyperinsulinaemia, other factors become operative in limiting the multiplication of cancer cells, possibly the availability of arachidonic acid, an essential membrane lipid constituent, or plasma glucose, an essential fuel for the energy metabolism of tumour cells and whose depletion is also involved in cachexic processes. In support of this view we find that, among the dietary oils, it is LSO which has the strongest hypoglycaemic effect in EL4 mice (Table V) while yielding the smallest size of this tumour (Table IV) . In addition, the inhibitory action of omega-3 fatty acids on PGE2 production by tumour cells, which has long been thought to be involved in tumorigenesis by weakening the immune defence system of the host, may counteract the stimulating effect of insulin.
We conclude that the insulinaemic and glycaemic status of the host may modify the inhibitory effects of omega-3 fatty acid-containing oils in some types of cancer.
